Study of TRC102 in Combination With Pemetrexed in Cancer Patients
NCT00692159
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasm
Interventions
DRUG:
TRC102 + pemetrexed
Sponsor
Tracon Pharmaceuticals Inc.